AIHP Announces Changes to Awards Program

Following a comprehensive review of the Institute’s awards program, AIHP’s Board of Directors has approved changes to three of the organization’s leading awards: the George Urdang Medal, the Edward Kremers Award, and the AIHP Glenn Sonnedecker Prize. Starting in 2021, the George Urdang Medal will become a lifetime achievement award and will recognize a person who, over aContinue reading “AIHP Announces Changes to Awards Program”

STRANGE TRIPS IN SASKATOON (MCNALLY ROBINSON) – REPORT

I recently launched Strange Trips: Science, Culture, and the Regulation of Drugs in my hometown of Saskatoon. And the event took place at my favourite independent bookstore, McNally Robinson. Approximately 30 people showed up. The Q&A was full and frank. I signed a bunch of books! Thanks to McGill-Queen’s University Press and McNally Robinson. SomeContinue reading “STRANGE TRIPS IN SASKATOON (MCNALLY ROBINSON) – REPORT”

Double Down

Every book has a back story. In the following series of posts, I share some thoughts about the inception, development, and completion of my new book, Strange Trips: Science, Culture, and the Regulation of Drugs. PART II From Saskatoon to Glasgow The second phase of writing my second book, Strange Trips, began in September ofContinue reading “Double Down”

London Calling

Every book has a back story. In the following series of posts, I share some thoughts about the inception, development, and completion of my new book, Strange Trips: Science, Culture, and the Regulation of Drugs. From London to Saskatoon The first phase of writing my second book, Strange Trips, began in 2010. It was aContinue reading “London Calling”

Fracture: The Paper Anniversary

Last summer, almost to the day, I fractured and dislocated my knee. Let’s just say it wasn’t pleasant. I was playing (soccer/football) and the tackle was “reckless and ridiculous.” Here’s my post from a year ago. So, on the anniversary of the tackle and an injury that sent my life in new directions, here areContinue reading “Fracture: The Paper Anniversary”

Grassroots Activism in Argentina: The Story of Mamá Cultiva, CAMEDA, and Medical Marijuana

Points: The Blog of the Alcohol & Drugs History Society Editor’s Note: This is the last post in our series from the Cannabis: Global Histories conference, held at the University of Strathclyde from April 19-20, 2018. It comes from Lucia Romero, an assistant researcher at CONICET (Argentina’s National Scientific and Technical Research Council). In it,Continue reading “Grassroots Activism in Argentina: The Story of Mamá Cultiva, CAMEDA, and Medical Marijuana”

The Right to Try

“Right to Try” (Again): A history of the experimental therapy movement  BY LUCAS RICHERT APRIL 16, 2018 CULTURE, HISTORY, POLITICS, RESEARCH   In recent weeks and months, momentum has increased on Capitol Hill to craft “right to try” laws that would profoundly change the medical landscape. The national legislation will allow terminally ill patients more access to experimental therapiesContinue reading “The Right to Try”

New Editors at Social History of Alcohol and Drugs

The ADHS is pleased to announce that the editorship of its journal, *The Social History of Alcohol and Drugs*, will be taken over by Prof. Nancy D. Campbell (Rensselaer Polytechnic Institute), Prof. David Herzberg (Buffalo) and Dr. Lucas Richert (Strathclyde). The society would also like to express its gratitude for the work that outgoing editor, […]Continue reading “New Editors at Social History of Alcohol and Drugs”

ADHS 2019

The ADHS is excited to announce that its next bi-annual conference will be held between 12 and 15 June 2019, at the David F. Musto Center for Drug Policy Studies, Shanghai University, China. The conference will be organised by Prof. Jim Mills, of the University of Strathclyde and Prof. Yong-an Zhang of Shanghai University, who […]Continue reading “ADHS 2019”

Big Pharma Round-Up V (#Cannabis edition)

Any of this stock market record due to Big Pharma boost from Jeff Sessions new memo against people's right to legal cannabis? https://t.co/HQotfSGzAl — Martha Densmore (@Acubody) January 4, 2018 Big Pharma wanted to sell more opioids. Then this happened..#opioidcrisis #opioid @conradhackett pic.twitter.com/rpHxGDeytW Alternatives, such as cannabis *cannot* overdose and are *way less* addictive —Continue reading “Big Pharma Round-Up V (#Cannabis edition)”